Pain News and Research

Latest Pain News and Research

Nordion celebrates first anniversary of market launch of TheraSphere

Nordion Inc., a leading provider of products and services to the global health science market, today celebrated the first anniversary of the market introduction of TheraSphere, an innovative radioembolic liver cancer therapy, in the Republic of Turkey.

17 Feb 2012

AstraZeneca launches ARIMIDEX Direct to help cancer patients

AstraZeneca today announced its first-ever direct-to-patient program offering patients with a valid prescription for ARIMIDEX or anastrozole the opportunity to have the brand ARIMIDEX delivered directly to their home by Express Scripts, a specialty pharmacy services provider, for $40 per month, including shipping.

17 Feb 2012

Cryoablation increases survival rates in ovarian cancer patients

Ovarian cancer, which killed 15,000 American women last year, is one of the deadliest forms of cancer. A team of Wayne State University School of Medicine researchers recently proved that freezing tumors increases survival rates in ovarian cancer patients.

17 Feb 2012

Hospital news: Colorado legislature considers limits on charges, Philly children's hospital apology, Mass. facility closure

Colorado's legislature is taking up a bill Thursday that would limit how much hospitals can charge people without insurance. ... The lawmaker who wrote it is trying to reduce the number of Coloradans bankrupted by medical bills.

16 Feb 2012

Injury Prevention in Active Youth

Over the past few decades there has been an increase in injury to youth participating in sport. The issue of youth sport injury has become a conundrum because if there is an increase in injury, then subsequently there is usually an increase in participation. With the insurgence of childhood obesity, youth participation in sporting activities has been encouraged.It has been proven that regularly scheduled physical activity is associated with health improvements and reduced incidence of disease.

16 Feb 2012

Acorda's fourth quarter GAAP net income increases to $12.7 million

Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2011.

16 Feb 2012

Controversy over psychiatric diagnosis reaches a fever pitch

As the Diagnostic and Statistical Manual of Mental Disorders is revised for the first time since 1994, controversy about psychiatric diagnosis is reaching a fever pitch.

16 Feb 2012

State roundup: Legislatures tackling abortion restrictions, Medicaid cuts/revamps, Rx drug abuse

A Republican supermajority has muscled two of the most restrictive anti-abortion bills in years through the Virginia House, including one that would all but outlaw the procedure in the state by declaring that the rights of persons apply from the moment sperm and egg unite. The bills passed over bitter yet futile objections from Democrats. And one GOP delegate caused the House to ripple when he said most abortions come as "matters of lifestyle convenience." ... The bills now go to the Senate

16 Feb 2012

Deep brain stimulation can also affect respiratory function

Deep brain stimulation (DBS) has become a common treatment for patients with chronic pain or movement disorders. Now a unique set of experiments shows that electrical stimulation in some of the same brain areas can also affect respiratory function, according to a study in the February issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

16 Feb 2012

Report illustrates great potential of integrative medicine in chronic health issues

A new survey of 29 integrative medicine centers around the U.S. found that 75 percent reported success using integrative practices to treat chronic pain and more than half reported positive results for gastrointestinal conditions, depression and anxiety, cancer and chronic stress.

16 Feb 2012

U.S. FDA accepts Pfizer's tafamidis NDA for treatment of TTR-FAP

Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tafamidis meglumine, the company's investigational, novel, oral therapy for the treatment of Transthyretin Familial Amyloid Polyneuropathy.

16 Feb 2012

Obesity may increase symptom severity and decrease QOL in patients with fibromyalgia

People with fibromyalgia can have difficulty getting a definitive diagnosis and finding an effective treatment plan. For many patients, the condition involves a confounding array of symptoms, including chronic pain, fatigue, sleep disturbance and mood disorders. One factor associated with fibromyalgia symptoms is a patient's weight, according to a Mayo Clinic study published on February 2012 in Arthritis Care & Research.

16 Feb 2012

Study: Diabetes may begin in the gut

Scientists at Washington University School of Medicine in St. Louis have made a surprising discovery about the origin of diabetes. Their research suggests that problems controlling blood sugar - the hallmark of diabetes - may begin in the intestines.

15 Feb 2012

Mencap accuses hospitals of discriminating against patients with learning disabilities

Mencap - a charity organization claimed today that 74 NHS patients with learning disabilities have needlessly died in the last decade because of discrimination. It accused the health system of failing to provide adequate care to those with learning disabilities.

15 Feb 2012

St. Jude Medical to examine cost-effectiveness of FFR-guided therapy in Australia, Asia

St. Jude Medical, Inc., a global medical device company, announced today it will evaluate the incremental cost-effectiveness of Fractional Flow Reserve (FFR)-guided treatment for patients with multivessel coronary artery disease in Japan, China, India, Korea, and Australia.

15 Feb 2012

Amoxicillin not effective for patients with acute rhinosinusitis

Treatment with the antibiotic amoxicillin for patients with acute uncomplicated rhinosinusitis (inflammation of the nasal cavity and sinuses) did not result in a significant difference in symptoms compared to patients who received placebo, according to a study in the February 15 issue of JAMA. Antibiotics are commonly used to treat this condition even though there is limited evidence supporting their effectiveness.

15 Feb 2012

Teva fourth quarter net revenues increase 28% to $5.7 billion

Teva Pharmaceutical Industries Ltd. today reported results for the quarter and year ended December 31, 2011.

15 Feb 2012

Curcumin prolongs life and enhances activity of fruit flies with AD

Curcumin, a substance extracted from turmeric, prolongs life and enhances activity of fruit flies with a nervous disorder similar to Alzheimers. The study conducted at Link-ping University, indicates that it is the initial stages of fibril formation and fragments of the amyloid fibrils that are most toxic to neurons.

15 Feb 2012

New group of compounds may protect brain cells from inflammation

Scientists at Emory University School of Medicine have identified a new group of compounds that may protect brain cells from inflammation linked to seizures and neurodegenerative diseases.

15 Feb 2012

New clinical guidelines for diagnosis and treatment of DVT

A researcher at Intermountain Medical Center in Salt Lake City is part of a select panel of international experts to help develop new evidence-based clinical guidelines used by physicians worldwide for the diagnosis and treatment of blood-clotting disorders, one of the most common cardiovascular diseases in the United States.

15 Feb 2012